-
Afternoon Market Top Percentage Gainers and Losers (CAAS, GENE, HNSN, SYMX, TPX, SCOK, QXM, IDIX, AIB, HERO)
Friday, April 8, 2011 - 1:58pm | 291Best 1) China Automotive Systems (NASDAQ: CAAS): Skyrocketing 36.49% to $11.14 after reporting that preliminary Q4 sales were ahead of consensus estimates. Looks like a short squeeze is underway. 2) Genetic Technologies (NASDAQ: GENE): Currently up 22.6% to $3.25. Shares have been surging since...
-
Afternoon Market Top Percentage Gainers and Losers (CAAS, GENE, SYMX, TPX, GY, SCOK, LIWA, IDIX, HERO, SGMO)
Friday, April 8, 2011 - 12:01pm | 260Best 1) China Automotive Systems (NASDAQ: CAAS): Skyrocketing 36.36% to $11.10 after reporting that preliminary Q4 sales were ahead of consensus estimates. Looks like a short squeeze is underway. 2) Genetic Technologies (NASDAQ: GENE): Currently up 20.38% to $3.19. Shares have been surging since...
-
Deutsche Bank Downgrades BRKR To Hold
Friday, April 8, 2011 - 7:15am | 81Deutsche Bank has issued a report downgrading Bruker Corp. (NASDAQ: BRKR) from Buy to Hold. According to Deutsche Bank, “We now see limited EPS upside vs. our FY11 forecast of $1.00 (above mgmt. guidance of $0.90-0.93) given tough stimulus comps and anemic outlook for government/academic research...
-
Piper Jaffray Raises PT On Illumina To $79
Friday, April 8, 2011 - 6:53am | 26Piper Jaffray has raised the price target on Illumina (NASDAQ: ILMN) from $76 to $79 and maintains its Overweight rating.
-
AMRI Announces Development and Commercial Supply Agreement with Parnell Manufacturing
Thursday, April 7, 2011 - 8:08am | 45AMRI (NASDAQ: AMRI) announced today that it has entered into a development and long term exclusive commercial supply agreement with Parnell Manufacturing Pty Ltd , an Australian company specializing in the research, development and manufacture of veterinary products.
-
Morgan Stanley Comments On WuXi Pharmatech's Growth
Wednesday, April 6, 2011 - 8:48am | 148WuXi Pharmatech's (NYSE: WX) stock has had a lackluster performance YTD even though the company delivered solid 2010 results and provided upbeat 2011 forecasts. Although Morgan Stanley thinks most investors have factored in the revenue potential from its core lab service business, Vertax...
-
Stocks Near Or Above 52-Week High (CERN, MCHP, PCS, WAT, DTE, GENZ)
Tuesday, April 5, 2011 - 11:38am | 135Cerner (NASDAQ: CERN) is currently trading at $114.92, which is at the 52-week high of $114.92. Microchip Technology (NASDAQ: MCHP) is currently trading at $38.66, which is at the 52-week high of $38.66. MetroPCS Communications (NYSE: PCS) is currently trading at $16.60, which is at the 52-week...
-
Goldman Sachs Comments On Illumina, Updates Its Model
Tuesday, April 5, 2011 - 9:38am | 154Goldman Sachs is adjusting its estimates on Illumina Inc. (NASDAQ: ILMN) to reflect its updated view on quarterly revenue pacing, recent financing activities, and corresponding share repurchase. Its 2011-2013 EPS estimates go to $1.48, $2.03, and $2.62 from $1.48, $2.00, and $2.58. Goldman...
-
JP Morgan Comments On Thermo Fisher Scientific Following Divestures, Buybacks
Tuesday, April 5, 2011 - 9:21am | 160With closure of the Quest Diagnostics acquisition of Athena Diagnostics this morning, JP Morgan is updating its Thermo Fisher Scientific (NYSE: TMO) estimates to reflect the divestitures, as well as share repurchases, convertible debt redemptions and new debt offerings. Due to J.P. Morgan's...
-
Caliper Announces New Oncology Research Collaboration
Tuesday, April 5, 2011 - 8:39am | 144Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced that its Caliper Discovery Alliances and Services unit has formed a research collaboration with Denver-based Catholic Health Initiatives, one of the nation's largest health systems. The health care system's Center for Translational...
-
Deutsche Bank Reiterates Buy Rating On CVD And ICLR
Tuesday, April 5, 2011 - 8:03am | 115Deutsche Bank is reiterating its Buy rating on shares of Covance Inc. (NYSE: CVD) and ICON plc (NASDAQ: ICLR). “Key takeaways from the Annual Partnerships in Clinical Trials Conference: 1) Vendor consolidation amongst biopharma clients (from 10-to-15 to 2-to-4) and momentum towards strategic deals...
-
BioDelivery Sciences Announces Completion of Recruitment in BEMA Buprenorphine Phase 3 Chronic Pain Study
Tuesday, April 5, 2011 - 7:18am | 159BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today completion of enrollment in its Phase 3 clinical trial assessing the efficacy and safety of BEMA Buprenorphine for the treatment of moderate to severe chronic pain. BDSI believes that there remains a significant unmet medical...
-
Reminder: Trading To Resume In CombiMatrix At 4:35pm (CBMX)
Monday, April 4, 2011 - 4:26pm | 18Reminder: Trading To Resume In CombiMatrix (NASDAQ: CBMX) At 4:35pm.
-
Thermo Fisher Scientific Extends Cash Tender Offer for Dionex Corporation
Monday, April 4, 2011 - 4:08pm | 91Thermo Fisher Scientific Inc. (NYSE: TMO) today announced that its previously announced tender offer to acquire all of the outstanding shares of Dionex Corporation (NASDAQ: DNEX) for $118.50 per share in cash has been extended and will now expire at 7:00 p.m., New York City time, on May 13, 2011,...
-
Piper Jaffray Updates On ILMN
Monday, April 4, 2011 - 8:50am | 100Piper Jaffray has issued a report updating on Illumina Inc (NASDAQ: ILMN) following meetings in Hong Kong. According to the report, "On the last day of our 5th Annual China Fieldtrip, we visited BGI Hong Kong, who is in the process of adding additional HiSeq's to their 82 current instruments....